VIRANON

Welcome to the Brand page for “VIRANON”, which is offered here for Pharmaceutical compositions for use in the treatment of immunologic diseases, lupus and rheumatoid arthritis and allergies, asthma, and viral illnesses, human immunodeficiency virus (hiv), acquired immune deficiency virus (aids), hepatitis and upper respiratory infections, and prevention of organ transplant rejection; immunomodulating kits consisting of unit dosages of one or more pharmaceutical compositions for lupus and rheumatoid arthritis, allergies, asthma, and viral illnesses, hiv, aids, hepatitis and upper respiratory infections, and prevention of organ transplant rejection, administrative devices in the nature of syringes, needles, inhalators, pills for the treatment of lupus and rheumatoid arthritis, allergies, asthma, and viral illnesses, hiv, aids, hepatitis and upper respiratory infections, and prevention of organ transplant rejection, suppositories, and transdermal delivery device in the nature of transdermal patches for the treatment of lupus and rheumatoid arthritis, allergies, asthma, and viral illnesses, hiv, aids, hepatitis and upper respiratory infections, and prevention of organ transplant refection, carrying case, and instruction booklet, all sold as a unit;.

Its status is currently believed to be active. Its class is unavailable. “VIRANON” is believed to be currently owned by “Immugen Pharmaceuticals, Inc.”